Australia markets close in 4 hours 55 minutes

CONMED Corporation (CNMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
61.90-8.11 (-11.58%)
At close: 04:00PM EDT
61.90 0.00 (0.00%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.16B
Enterprise value 3.11B
Trailing P/E 34.32
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.77
Price/book (mrq)2.58
Enterprise value/revenue 2.49
Enterprise value/EBITDA 16.13

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-45.38%
S&P500 52-week change 322.64%
52-week high 3138.47
52-week low 361.05
50-day moving average 378.93
200-day moving average 399.46

Share statistics

Avg vol (3-month) 3564.32k
Avg vol (10-day) 3629.48k
Shares outstanding 530.79M
Implied shares outstanding 634.83M
Float 830.51M
% held by insiders 10.54%
% held by institutions 1119.64%
Shares short (15 Apr 2024) 43.89M
Short ratio (15 Apr 2024) 48.08
Short % of float (15 Apr 2024) 417.55%
Short % of shares outstanding (15 Apr 2024) 412.65%
Shares short (prior month 15 Mar 2024) 43.93M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 41.14%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 30.86%
5-year average dividend yield 40.79
Payout ratio 439.22%
Dividend date 305 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 310 Sept 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.53%
Operating margin (ttm)11.21%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.26B
Revenue per share (ttm)41.05
Quarterly revenue growth (yoy)5.70%
Gross profit (ttm)N/A
EBITDA 219.63M
Net income avi to common (ttm)82.35M
Diluted EPS (ttm)1.80
Quarterly earnings growth (yoy)983.50%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)118.82%
Current ratio (mrq)N/A
Book value per share (mrq)27.12

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A